Product
Trilaciclib + Pemetrexed
1 clinical trial
1 indication
Indication
NSCLCClinical trial
A Prospective, Single-arm, and Exploratory Phase II Clinical Study of Trilaciclib Combined With Lateral Ventricular Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer With Leptomeningeal MetastasisStatus: Recruiting, Estimated PCD: 2024-11-01